Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

October 10, 2019

Study Completion Date

March 31, 2020

Conditions

Mucositis

Interventions

DRUG

TK-112690

TK112690 treatment pre-methotrexate treatment

DRUG

Placebo TK-112690

Placebo

Trial Locations (3)

Bangalore Cancer, Bangalore

Karnatak Cancer Therapy and Research Institute, Navanagar

Netaji Subhash Chandra Bose Cancer Hospital, Kolkata